News

Bio-Path Holdings Reports Second Quarter 2023 Financial Results

Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH),…

1 year ago

Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023

Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and…

1 year ago

Gritstone bio and Genevant Sciences Announce Option and License Agreement

Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of…

1 year ago

MCI Onehealth Reports Second Quarter 2023 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, ON, Aug. 15, 2023 (GLOBE…

1 year ago

AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update

– Continued operational execution across pipeline towards multiple clinical and regulatory value-driving milestones expected in the second half of 2023…

1 year ago

Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team

RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Merakris Therapeutics has added two new executives to its leadership…

1 year ago

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Announced pricing of approximately $5 million equity financing (approximately $5.7 million if underwriter’s overallotment option is exercised in full); expected…

1 year ago

Interactive Strength Inc. d/b/a FORME Reports Second Quarter 2023 Results

Net Loss and Earnings per Diluted Share of $13.6 million and $1.02 Adjusted EBITDA was a $5.7 million loss, a…

1 year ago

TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock

FORT WORTH, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company…

1 year ago

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on…

1 year ago